ILONOV Overview
- Headquarters
- Strasbourg, Bas-rhin, Fr
- Industry
- Biotechnology Research
- Employees
- 5
- Founded
- 2020
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About ILONOV
The European Diabetes Study Center has gathered a team of renowned scientific and medical experts, pioneers in their field of expertise, to fund a biotech company, ILONOV, focused on developing a novel class of therapeutics using the therapeutic potential of our muscle-derived biologic. We aim at satisfying unmet medical needs in Type 1 Diabetes therapy by bringing to the market a first-in-class treatment for curing and preventing T1D and using our discovery to open up a new field of therapeutics.
ILONOV Contact Details
- People in AeroLeads
- 3
ILONOV Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Marie-Charlotte Lechner, Phd | Preclinical & Innovation Project |
View
|
|
| Ahmad Rida | Pharmacist Phd in Molecular | Strasbourg, Grand Est, France |
View
|
| Karim Bouzakri | Président Chez Ilonov |
View
|
Employees by Management Level
Individual contributor
3 profiles
Compare Similar Companies to ILONOV
Domain Therapeutics
Pharmaceutical Manufacturing
NETRI
Biotechnology Research
BioValley France
Biotechnology
Hocoia
Public Health
Continuum Plus Santé
Home Health Care Services
BaseLaunch
Biotechnology Research
SUPERBRANCHE
Nanotechnology Research
BiPER Therapeutics
Biotechnology Research
T-Oncology AG
Biotechnology Research
Selmod
Biotechnology Research